OpenURL Connection Search

Select item for more details and to access through your institution.

Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization.
Published in:
Biochemistry (00062979), 2022, v. 87, n. 4, p. 319, doi. 10.1134/S0006297922040022
By:
- Karyagina, Anna S.;
- Gromov, Alexander V.;
- Grunina, Tatyana M.;
- Lyaschuk, Alexander M.;
- Poponova, Maria S.;
- Kleymenov, Denis A.;
- Strukova, Natalia V.;
- Generalova, Maria S.;
- Ryazanova, Anna V.;
- Galushkina, Zoya M.;
- Dobrynina, Olga Yu.;
- Bolshakova, Tatyana N.;
- Sergeeva, Maria V.;
- Romanovskaya-Romanko, Ekaterina A.;
- Krasilnikov, Igor V.;
- Subbotina, Marina E.;
- Lunin, Vladimir G.
Publication type:
Article
Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.
Published in:
Biochemistry (00062979), 2021, v. 86, n. 10, p. 1275, doi. 10.1134/S0006297921100096
By:
- Karyagina, Anna S.;
- Gromov, Alexander V.;
- Grunina, Tatyana M.;
- Lyaschuk, Alexander M.;
- Grishin, Alexander V.;
- Strukova, Natalia V.;
- Generalova, Maria S.;
- Galushkina, Zoya M.;
- Soboleva, Lyubov' A.;
- Dobrinina, Olga Yu.;
- Bolshakova, Tatyana N.;
- Subbotina, Marina E.;
- Romanovskaya-Romanko, Ekaterina A.;
- Krasilnikov, Igor V.;
- Polyakov, Nikita B.;
- Solovyev, Andrey I.;
- Grumov, Daniil A.;
- Zhukhovitsky, Vladimir G.;
- Ryabova, Ekaterina I.;
- Prokofiev, Vladimir V.
Publication type:
Article
Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2.
Published in:
Vaccines, 2024, v. 12, n. 10, p. 1200, doi. 10.3390/vaccines12101200
By:
- Vakhrusheva, Anna V.;
- Romanovskaya-Romanko, Ekaterina A.;
- Stukova, Marina A.;
- Sukhova, Maria M.;
- Kuznetsova, Ksenia S.;
- Kudriavtsev, Aleksandr V.;
- Frolova, Maria E.;
- Ivanishin, Taras V.;
- Krasilnikov, Igor V.;
- Isaev, Artur A.
Publication type:
Article
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Published in:
Vaccines, 2023, v. 11, n. 2, p. 326, doi. 10.3390/vaccines11020326
By:
- Kudriavtsev, Aleksandr V.;
- Vakhrusheva, Anna V.;
- Kryuchkov, Nickolay A.;
- Frolova, Maria E.;
- Blagodatskikh, Konstantin A.;
- Ivanishin, Taras V.;
- Djonovic, Milana;
- Romanovskaya-Romanko, Ekaterina A.;
- Kovalenko, Anton N.;
- Lioznov, Dmitry A.;
- Zubkova, Tatiana G.;
- Teplykh, Svetlana V.;
- Oseshnyuk, Rodion A.;
- Stukova, Marina A.;
- Isaev, Artur A.;
- Krasilnikov, Igor V.
Publication type:
Article
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Published in:
Vaccines, 2022, v. 10, n. 8, p. 1290, doi. 10.3390/vaccines10081290
By:
- Vakhrusheva, Anna V.;
- Kudriavtsev, Aleksandr V.;
- Kryuchkov, Nickolay A.;
- Deev, Roman V.;
- Frolova, Maria E.;
- Blagodatskikh, Konstantin A.;
- Djonovic, Milana;
- Nedorubov, Andrey A.;
- Odintsova, Elena;
- Ivanov, Aleksandr V.;
- Romanovskaya-Romanko, Ekaterina A.;
- Stukova, Marina A.;
- Isaev, Artur A.;
- Krasilnikov, Igor V.
Publication type:
Article
Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2.
Published in:
Vaccines, 2022, v. 10, n. 1, p. 69, doi. 10.3390/vaccines10010069
By:
- Krasilnikov, Igor V.;
- Kudriavtsev, Aleksandr V.;
- Vakhrusheva, Anna V.;
- Frolova, Maria E.;
- Ivanov, Aleksandr V.;
- Stukova, Marina A.;
- Romanovskaya-Romanko, Ekaterina A.;
- Vasilyev, Kirill A.;
- Mushenkova, Nataliya V.;
- Isaev, Artur A.
Publication type:
Article
Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
Published in:
Influenza & Other Respiratory Viruses, 2012, v. 6, n. 3, p. 188, doi. 10.1111/j.1750-2659.2011.00291.x
By:
- Gambaryan, Alexandra S.;
- Lomakina, Natalia F.;
- Boravleva, Elizaveta Y.;
- Kropotkina, Ekaterina A.;
- Mashin, Vadim V.;
- Krasilnikov, Igor V.;
- Klimov, Alexander I.;
- Rudenko, Larisa G.
Publication type:
Article

Found: 7

Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization.

Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.

Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.

Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2.

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).